Back to Authors

Bejarano, P.A.

Mayo Clinic

Cleveland Clinic Florida

Citations 1

Colorectal Carcinoma With Sarcomatoid Components
Golconda, Umamaheshwari, McHugh, Kelsey , Allende, Daniela , Collins, Katrina , Henn, Patrick, Lacambra, Maribel D. , Bejarano, P.A., Groisman, Gabriel M. , Zhang, Xuchen , McHugh, Kelsey E , Loughrey, Maurice Bernard , Monappa, Vidya , Hornick, Jason L. , González, Raul S.

American Journal of Surgical Pathology | December 29, 2023 | Volume: 48 | Issue: 4 | Pages: 465-474

10.1097/pas.0000000000002172 Get It

Colorectal carcinoma with sarcomatoid components (which includes so-called carcinosarcomas and sarcomatoid carcinomas) is a rare subtype with 50 reported cases in the literature and overlapping criteria with undifferentiated carcinoma. We collected and described 15 cases from 10 men and 5 women, with a mean age of 66 years. Symptoms included abdominal pain and gastrointestinal bleeding. Most tumors presented in the rectosigmoid region, with a mean size of 8.2 cm. The sarcomatoid component, on average, represented 58% of the tumors and took many forms, including spindled (10 cases), anaplastic (9 cases), and rhabdoid (3 cases); one case showed osteoid matrix. Tumor budding was usually high, and tumor-infiltrating lymphocytes were usually low. The sarcomatoid component was keratin-positive in 10 cases. One case showed loss of mismatch repair protein expression, and 2 cases showed SMARCA4 loss (1 also with SMARCA2 loss). Molecular testing identified mutations in KRAS (n=1), NRAS (n=2), BRAF (n=2), APC (n=1), and TP53 (n=1) in a few cases. Tumors often presented at advanced stage, with 11 cases pT4, 9 cases with nodal metastases, and 7 cases with distant metastases. Follow-up was available for 10 cases (median: 2 months), with 2 alive without disease, 3 alive with disease, and 5 dead. Our findings roughly corresponded with those in previously reported cases. Colorectal carcinoma with sarcomatoid components is rare and aggressive, with a poor prognosis for many patients. We suggest that spindled cells, anaplasia, heterologous elements, and/or a component with definable sarcomatous lineage be used to distinguish colorectal carcinoma with sarcomatoid components from undifferentiated carcinoma.